Sandoz
Switzerland · Pharma & Healthcare
LeaveRussia detail: Continue Operations
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz.
Decision trail
Decision date 05/04/2024 · Reference ↗
Have decided to suspend any investment in Russia as well as commercial marketing activities. The company did not stop working in Russia. The Russian website is working. In October 2023, the general director was changed. Staff are being recruited.
Local stats (LeaveRussia)
Assets(RF), mln.USD
200
Capital(RF), mln.USD
72
Revenue(RF), mln.USD
285
Staff(RF), 2021
1088
Glob.Revenue, mln.USD
9647
Status history since 2022
- 03/08/2026 — operating · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional